Back to Agenda
Power Learning Session 3: Pharma Marketing and the Role of BBB National Programs’ National Advertising Division
Session Chair(s)
Bob Dean, MBA
Head of Global Labeling Strategy & Ad/Promo
EMD Serono, United States
Join this session to gain insight into how to uphold industry standards in pharmaceutical advertising from the National Programs’ National Advertising Division's (NAD). We will explore a recent case study where the NAD took action to remove misleading drug claims, offering a real-world example of their commitment to consumer protection. Discover how NAD's rigorous examination of pharmaceutical promotions ensures accurate information and safeguards public health. This session is an opportunity to learn about NAD's vital role and how it can be a resource in maintaining transparency and building integrity in the pharmaceutical sector.
Learning Objective :
- Describe BBB National Programs and NAD’s role in Pharma promotion
- Compare NAD actions with those of the FDA’s OPDP
- Apply newly acquired knowledge with internal stakeholders
Speaker(s)
Pharma Marketing and the role of BBB National Programs’ National Advertising Division
Laura Brett
BBB National Programs, United States
Vice President, National Advertising Division
Have an account?